Paratek

Developing transformative solutions for patients with infectious diseases and other difficult to treat conditions.

[Paratek @ParatekPharma]

At #IDWeek2026, we’ll present new data on omadacycline across a range of pathogens and infectious disease settings. We’re also pleased to support investigator-initiated research that deepens understanding in these important areas of need.
Learn more: https://t.co/2L45AcCKCv

[Paratek @ParatekPharma]

Today, Paratek celebrates 30 years of innovation, resilience, and patient impact. Thank you to the employees, partners, healthcare professionals, and patients who have been part of our journey.

Built on Resilience. Moving Forward with Purpose.

#Paratek30 #Biotech #PatientImpact

[Paratek @ParatekPharma]

Paratek is advancing science in areas of high unmet need in infectious diseases.

At #ESCMIDGlobal2026, we’ll present new clinical, non-clinical, and real-world data – including investigator-sponsored research to help deepen understanding and inform care: https://t.co/idgTZ7Jzp4

[Paratek @ParatekPharma]

Grateful to @RepDean for visiting and for her dedication to the life sciences community in Southeast PA.

We share a commitment to advancing science, strengthening public health, and ensuring patients and health care providers have access to life-saving treatments.

[Congresswoman Madeleine Dean @RepDean]

Montgomery County is a hub for science and medicine, so I was delighted to visit Paratek, a biopharmaceutical company in KOP focused on the development of antibiotics.

I'm thankful for their commitment to life-saving innovation.

[Paratek @ParatekPharma]

We were honored to welcome @RepDean to our PA offices. The discussion underscored a shared focus on scientific leadership, innovation, and future growth.

Thank you for your engagement & recognition of the importance of a thriving biotech ecosystem in Southeast PA.

[Paratek @ParatekPharma]

Paratek today announced the completion of its combination with Radius Health, creating a diversified portfolio and advancing Paratek’s growth strategy of building a pharmaceutical platform in high-need, targeted therapeutic areas.

Learn more: https://t.co/ak9lwpj8nP

[Paratek @ParatekPharma]

Paratek has achieved another milestone! Positive NUZYRA (omadacycline) efficacy results have triggered additional @BARDA procurement, advancing our shared commitment to public health preparedness.
Learn more here: https://t.co/djX93LySAs

[Paratek @ParatekPharma]

We’re joining the global infectious disease community at #IDWeek2025 and #CHEST2025 next week to share new clinical and microbiologic data advancing understanding of community-acquired infections and public health preparedness. https://t.co/au9mNIyc4A

[Paratek @ParatekPharma]

Aligning with our commitment to advancing patient outcomes, Paratek will be at #AANP25 in San Diego, June 17-22.

Find us at Booth 1704, ready to discuss managing ABSSSI and CABP. @AANP_NEWS https://t.co/0TQPbVxRu9

[Paratek @ParatekPharma]

Scouting partnerships at #BIO2025? Let's talk biotech in Boston.
Secure your time to connect with Paratek's @LironSissman, MBA, VP, Business Development, through BIO Partnering, June 16-19. #PharmaPartnerships

[Paratek @ParatekPharma]

Paratek Pharmaceuticals Completes Acquisition of Optinose, Creating an Expanded Portfolio of Specialty Therapies. Read today's news: https://t.co/h3OqppVrVR

[Paratek @ParatekPharma]

We’re gearing up for the Symposium on Advanced Wound Care (SAWC) & Wound Healing Society (WHS) meeting in Grapevine, TX, from May 1-3! Stop by booth #732 to connect with our team and discuss infection management in wound care. See you there!

[Paratek @ParatekPharma]

Happy Administrative Professionals Day! Today, we celebrate the dedicated professionals who keep everything running behind the scenes. Thank you for your hard work and invaluable support, you help make our mission at Paratek possible every day!

[Paratek @ParatekPharma]

Thrilled to recognize Chris Hensley, Exec. Director of Trade Relations & Patient Services, as this year’s Levy-Gilbert CEO Award honoree. Congrats to Chris and all the finalists whose work continues to raise the bar. #ParatekProud

[Paratek @ParatekPharma]

ICYMI: Paratek shared new data at #ESCMID2025 with implications for patient care and public health preparedness.

Thanks, @ESCMID, for fostering global scientific progress. https://t.co/AkA2633Dra

[Paratek @ParatekPharma]

NOW OPEN: The 2025 @Vivli #AMRSurveillance Data Challenge is accepting submissions!
We're proud to support this global competition which helps researchers turn innovation into impact in the fight against AMR. Learn more and apply: https://t.co/1n7nBi5Qjo

[Paratek @ParatekPharma]

On National Public Health Week, we celebrate the critical work of healthcare professionals and researchers in improving patient care. At Paratek, we are committed to advancing treatment options that support patient health and safety. #ThankYouPublicHealth

[Paratek @ParatekPharma]

Paratek continues to invest in the future of infectious disease science.

At #ESCMID2025, data from several new studies highlighting non-clinical and real-world patient use data will be presented.

Read today's release & explore our @ESCMID presentations: https://t.co/Jfw6bBJ5a1

[Paratek @ParatekPharma]

That’s a wrap on the# ACFAS2025 conference! It was great connecting with healthcare professionals at booth 732.

Thank you to everyone who stopped by to engage with our team. If you didn’t get a chance to connect, we’d love to see you next time!

[Paratek @ParatekPharma]

Paratek is expanding its portfolio with its planned acquisition of Optinose. Leveraging our commercial expertise and established presence in primary care and specialty markets, we will be able to reach more patients with innovative therapies. https://t.co/3VIDqryEl8